Neptune Technologies & Bioresources Inc PE Ratio 2009-2018 | NEPT

Current and historical p/e ratio for Neptune Technologies & Bioresources Inc (NEPT) from 2009 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Neptune Technologies & Bioresources Inc PE ratio as of February 21, 2019 is 0.00.
Neptune Technologies & Bioresources Inc PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-02-21 3.72 0.00
2018-12-31 2.54 $-0.07 0.00
2018-09-30 3.88 $-0.07 0.00
2018-06-30 3.10 $-0.04 0.00
2016-11-30 1.02 $0.01 102.00
2016-08-31 0.98 $0.01 97.99
2016-05-31 1.21 $-0.01 0.00
2016-03-31 1.00 $-0.03 0.00
2016-02-29 1.12 $-0.09 0.00
2015-12-31 1.07 $-0.19 0.00
2015-09-30 1.10 $-0.18 0.00
2015-06-30 1.29 $-0.31 0.00
2015-03-31 1.62 $-0.32 0.00
2014-12-31 1.90 $-0.22 0.00
2014-09-30 1.93 $-0.34 0.00
2014-06-30 2.76 $-0.25 0.00
2014-03-31 2.48 $-0.26 0.00
2013-12-31 2.90 $-0.27 0.00
2013-09-30 3.18 $-0.14 0.00
2013-06-30 3.25 $-0.29 0.00
2013-03-31 2.52 $-0.30 0.00
2013-02-28 2.60 $-0.31 0.00
2012-12-31 2.01 $-0.32 0.00
2012-09-30 3.95 $-0.12 0.00
2012-06-30 4.74 $-0.08 0.00
2012-03-31 3.15 $-0.09 0.00
2011-12-31 2.92 $-0.03 0.00
2011-09-30 2.54 $0.02 127.00
2011-06-30 3.75 $0.07 53.57
2011-03-31 2.24 $0.11 20.36
2010-12-31 2.48 $0.06 41.33
2010-09-30 2.10 $0.07 30.00
2010-06-30 1.14 $0.02 57.00
2010-03-31 1.98 $-0.03 0.00
2009-12-31 2.06 $-0.03 0.00
2009-09-30 1.79 $-0.12 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.294B $0.022B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14